期刊文献+
共找到194篇文章
< 1 2 10 >
每页显示 20 50 100
Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates 被引量:22
1
作者 Anuradha Shenoy-Bhangle Vinit Baliyan +2 位作者 Hamed Kordbacheh Alexander R Guimaraes Avinash Kambadakone 《World Journal of Hepatology》 CAS 2017年第26期1081-1091,共11页
Diffusion-weighted imaging(DWI), a functional imaging technique exploiting the Brownian motion of water molecules, is increasingly shown to have value in various oncological and non-oncological applications. Factors s... Diffusion-weighted imaging(DWI), a functional imaging technique exploiting the Brownian motion of water molecules, is increasingly shown to have value in various oncological and non-oncological applications. Factors such as the ease of acquisition and ability to obtain functional information in the absence of intravenous contrast, especially in patients with abnormal renal function, have contributed to the growing interest in exploring clinical applications of DWI. In the liver, DWI demonstrates a gamut of clinical applications ranging from detecting focal liver lesions to monitoring response in patients undergoing serial follow-up after loco-regional and systemic therapies. DWI is also being applied in the evaluation of diffuse liver diseases such as non-alcoholic fatty liver disease, hepatic fibrosis and cirrhosis. In this review, we intend to review the basic principles, technique, current clinical applications and future trends of DW-MRI in the liver. 展开更多
关键词 liver imaging Diffusion weighted imaging Magnetic resonance imaging Focal liver lesion Diffuse liver disease Response assessment
下载PDF
^99mTc-DTPA-半乳糖人血清白蛋白在不同小鼠肝损伤模型中肝功能显像的应用 被引量:17
2
作者 毛一雷 董一女 +4 位作者 张现忠 杨文江 杜顺达 童俊翔 王学斌 《中国医学科学院学报》 CAS CSCD 北大核心 2008年第4期404-408,I0001,I0002,共7页
目的明确肝显像剂99mTc-DTPA-半乳糖人血清白蛋白(99mTc-GSA)在3种不同类型肝细胞损伤小鼠模型中不同的摄取和生物分布情况。方法3种小鼠模型分别为肝硬化、淤胆性肝损伤和肝肿瘤模型。肝硬化模型用腹腔内注射CCl4完成(每48小时腹腔注射... 目的明确肝显像剂99mTc-DTPA-半乳糖人血清白蛋白(99mTc-GSA)在3种不同类型肝细胞损伤小鼠模型中不同的摄取和生物分布情况。方法3种小鼠模型分别为肝硬化、淤胆性肝损伤和肝肿瘤模型。肝硬化模型用腹腔内注射CCl4完成(每48小时腹腔注射0.4 ml 10%CCl4,共48 d);淤胆性肝损伤模型以结扎胆总管72 h建立;肝肿瘤模型用H22肿瘤细胞株种植肝包膜下10 d建立。各模型组小鼠和正常对照组小鼠均以0.1 ml(0.37 MBq)99mTc-GSA(2μg)注射尾静脉,5 min后断头处死,取出各重要器官或组织(肝脏、心脏、肺脏、肾脏、脾脏、胃、血液、骨骼、肌肉、肠道)称量,测定其放射性计数。同时血清学及肝脏病理学检查验证肝脏损伤。结果3个模型组和对照组中99mTc-GSA在小鼠肝脏均有显著浓聚(均>40%ID.g-1),但与对照组(90.05±10.55)%ID.g-1相比,肝损伤模型组的浓聚度均显著下降(P<0.001)。病理检查结果和建立模型时预期的病变相符;血清肝功能显示肝硬化模型组的损伤[天冬氨酸转氨酶为(235.3±14.7)U/L]轻于淤胆性肝损伤模型以及肝肿瘤模型[天冬氨酸转氨酶分别为(841.3±68.7)和(1 060.3±208.3)U/L];但肝硬化模型的浓聚度(72.20±2.13)%ID.g-1较淤胆性肝损伤模型(56.72±5.92)%ID.g-1及肝肿瘤模型(42.80±6.05)%ID.g-1显著增高(P<0.001)。结论99mTc-GSA在肝脏有显著浓聚,其浓聚程度与肝功能受损情况呈负相关。99mTc-GSA可能成为临床上反映肝功能的显像剂,如与三维扫描技术相结合,有希望建立评估肝脏区段功能的三维成像系统。 展开更多
关键词 肝脏显像 去唾液酸糖蛋白受体显像剂 ^99mTc-DTPA半-乳糖人血清白蛋白 肝损伤模型
下载PDF
Extended central hepatectomy with preservation of segment 6 for patients with centrally located hepatocellular carcinoma 被引量:10
3
作者 Mahmoud Abdelwahab Ali Jung-Fang Chuang +3 位作者 Chee-Chien Yong Chih-Chi Wang Chi-Ying Lin Chao-Long Chen 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2015年第1期63-68,共6页
BACKGROUND: In order to preserve functional liver parenchyma, extended central hepatectomy (segments 4, 5, 7 and 8 resection) was proposed for the management of centrally located hepatocellular carcinoma invading t... BACKGROUND: In order to preserve functional liver parenchyma, extended central hepatectomy (segments 4, 5, 7 and 8 resection) was proposed for the management of centrally located hepatocellular carcinoma invading the right and middle hepatic veins, reconstructing segment 6 outflow in the absence of the thick inferior right hepatic vein. The present study was to describe our surgical techniques of extended central hepatectomy.METHODS: Between 2008 and 2012, 5 patients with centrally located hepatocellular carcinoma invading or in the vicinity of the right and middle hepatic veins underwent extended central hepatectomy. The thick inferior right hepatic vein was preserved during dissection. Gore-Tex graft was used for segment 6 outflow reconstruction in the absence of the thick inferior right hepatic vein.RESULTS: The mean future remnant liver volume for segments 2 and 3 was 28% versus 45% on segment 6 preservation. The mean tumor diameter was 7.4 cm. The thick inferior right hepatic vein was found in 1 patient. Outflow reconstruction from segment 6 was performed in 4 patients. Postoperative complications included bile leakage (1 patient), pleural effusion (2) and liver failure (1). The rate of graft patency was 75%. There was no perioperative mortality.CONCLUSION: Extended central hepatectomy is a safe alternative for extended hepatic resection in selected patients attempting to preserve the functional liver parenchyma. 展开更多
关键词 HEPATECTOMY hepatic vein thrombosis hepatocellular carcinoma liver cirrhosis liver imaging
下载PDF
Application of computer-assisted three-dimensional quantitative assessment and a surgical planning tool for living donor liver transplantation 被引量:9
4
作者 WEI Lin ZHU Zhi-jun +4 位作者 LU Yi JIANG Wen-tao GAO Wei ZENG Zhi-gui SHEN Zhong-yang 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第7期1288-1291,共4页
Background Precise evaluation of the live donor's liver is the most important factor for the donor's safety and the recipient's prognosis in living donor liver transplantation (LDLT). Our study assessed the clini... Background Precise evaluation of the live donor's liver is the most important factor for the donor's safety and the recipient's prognosis in living donor liver transplantation (LDLT). Our study assessed the clinical value of computer-assisted three-dimensional quantitative assessment and a surgical planning tool for donor evaluation in LDLT. Methods Computer-assisted three-dimensional (3D) quantitative assessment was used to prospectively provide quantitative assessment of the graft volume for 123 consecutive donors of LDLT and its accuracy and efficiency were compared with that of the standard manual-traced method. A case of reduced monosegmental LDLT was also assessed and a surgical planning tool displayed the precise surgical plan to avoid large-for-size syndrome. Results There was no statistically significant difference between the detected graft volumes with computer-assisted 3D quantitative assessment and manual-traced approaches ((856.76±162.18) cm3 vs. (870.64±172.54) cm3, P=0.796). Estimated volumes by either method had good correlation with the actual graft weight (r-manual-traced method: 0.921, r-3D quantitative assessment method: 0.896, both P 〈0.001). However, the computer-assisted 3D quantitative assessment approach was significantly more efficient taking half the time of the manual-traced method ((16.91±1.375) minutes vs. (39.27±2.102) minutes, P 〈0.01) to estimate graft volume. We performed the reduced monosegmental LDLT, a pediatric case, with the surgical planning tool (188 g graft in the operation, which was estimated at 208 cm3 pre-operation). The recipient recovered without large-for-size syndrome. Conclusions Computer-assisted 3D quantitative assessment provided precise evaluation of the graft volume. It also assisted surgeons with a better understanding of the hepatic 3D anatomy and was useful for the individual surgical planning tool. 展开更多
关键词 living donor liver transplantation liver imaging computed tomography anatomy safety
原文传递
速效降脂舒肝汤治疗非酒精性脂肪肝临床研究 被引量:10
5
作者 陶杨 左玉江 +3 位作者 王东宁 郝天鹏 楚二伟 曲亚罡 《中医学报》 CAS 2017年第3期444-448,共5页
目的:观察速效降脂舒肝汤治疗非酒精性脂肪肝的临床疗效。方法:78例非酒精性脂肪性肝炎患者随机分为对照组和观察组,每组39例。对照组给予多烯磷脂酰胆碱胶囊,观察组在对照组治疗基础上给予速效降脂舒肝汤。治疗结束后,比较两组血脂、... 目的:观察速效降脂舒肝汤治疗非酒精性脂肪肝的临床疗效。方法:78例非酒精性脂肪性肝炎患者随机分为对照组和观察组,每组39例。对照组给予多烯磷脂酰胆碱胶囊,观察组在对照组治疗基础上给予速效降脂舒肝汤。治疗结束后,比较两组血脂、肝功能以及肝纤维化指标的变化,观察肝脏B超和肝脏及脾脏CT检查的变化,并比较临床疗效。结果:与治疗前比较,两组总胆固醇(total cholesterol,TC)、三酰甘油(triacylglycerol,TG)以及低密度脂蛋白(low density lipoprotein,LDL)水平降低(P<0.01),高密度脂蛋白(high density lipoprotein,HDL)水平升高(P<0.01),总胆红素(total bilirubin,TBIL)、γ-谷氨酰转肽酶(gamma-glutamyl transpeptidase,γ-GT)、丙氨酸转氨酶(alanine aminotransferase,ALT)以及天门冬氨酸氨基转移酶(aspartate amino transferase,AST)水平均降低(P<0.01),血清层黏蛋白(laminin,LN)、透明质酸(hyaluronic acid,HA)、Ⅲ型前胶原(procollagen III,PCⅢ)以及Ⅳ型胶原(collagen type IV,Ⅳ-C)水平均降低(P<0.01),肝脏B超积分降低(P<0.01),肝脾CT比值升高(P<0.01);与对照组比较,观察组TC、TG以及LDL水平较低(P<0.01),HDL水平较高(P<0.01),TBIL、γ-GT、ALT以及AST水平均较低(P<0.01),LN、HA、PCⅢ以及Ⅳ-C水平均较低(P<0.01),肝脏B超积分较低(P<0.01),肝脾CT比值较高(P<0.01);对照组有效率为48.72%,观察组有效率为76.92%,两组有效率比较,差异有统计学意义(P<0.05)。结论:速效降脂舒肝汤治疗非酒精性脂肪性肝炎临床疗效显著,能抑制肝纤维化,改善肝脏影像学及肝功能。 展开更多
关键词 非酒精性脂肪性肝炎 速效降脂舒肝汤 肝纤维化 肝脏影像学 中西医结合
下载PDF
256层CT全肝灌注及一站式成像在肝硬化合并肝癌患者术前的应用探讨 被引量:7
6
作者 李良才 唐秉航 +3 位作者 张丽萍 黄德成 余元龙 胡泽民 《黑龙江医学》 2015年第2期134-136,共3页
目的探讨256层CT全肝灌注及一站式成像对肝硬化合并肝癌的诊断及其在肝储备功能评价中的应用价值。方法采用CT形态学分级方法对35例临床确诊为肝硬化合并肝癌的患者进行轻、中、重3级肝硬化程度划分(其中轻度10例、中度15例、重度10例)... 目的探讨256层CT全肝灌注及一站式成像对肝硬化合并肝癌的诊断及其在肝储备功能评价中的应用价值。方法采用CT形态学分级方法对35例临床确诊为肝硬化合并肝癌的患者进行轻、中、重3级肝硬化程度划分(其中轻度10例、中度15例、重度10例),所有患者均行CT全肝灌注扫描,分析其CT灌注值差异以及CT形态学分级与Child-Pugh分级之间的关系;同时依据时间-密度曲线(TDC),在原始数据中选取动脉期、门脉期及平衡期图像进行形态学分析。结果 (1)不同级别肝硬化的门静脉灌注量(PVP)、总肝灌注量(TLP)和肝动脉灌注指数(HPI)值间有显著统计学差异,PVP、TLP随着肝硬化程度的加重呈逐渐递减趋势,HAP、HPI则呈逐渐递增趋势;(2)CT肝硬化形态学分级与肝功能Child-Pugh分级呈显著正相关(r=0.831,P<0.001);(3)从灌注原始数据可获得相当于常规平扫及动态扫描的动脉期、门脉期和平衡期图像,图像质量满足肝脏常规动态扫描形态学分析标准,肿瘤强化特征与对应灌注彩图具较高一致性,并可以进行肝脏、肿块的3D体积测量。结论 256层螺旋CT全肝灌注实现了肝脏功能和形态的一站式成像,CT灌注值可作为评价肝硬化合并肝癌患者肝硬化程度和肝储备功能的重要指标,对外科肝切除术前综合因素评估具有良好临床应用前景。 展开更多
关键词 肝硬化 肝癌 肝脏成像 体层摄影术X线计算机
下载PDF
机器学习及其在肝脏疾病影像诊断中的研究进展 被引量:6
7
作者 刘文广 谢斯敏 +3 位作者 周雅芳 胡家熙 李梦思 李文政 《国际医学放射学杂志》 北大核心 2019年第1期16-21,共6页
机器学习(ML)是指计算机通过大量数据训练及分析来模拟人类的学习行为从而获得新的知识和技能,是人工智能的核心。目前,ML在肝脏疾病方面的研究因影像分割困难而相对较少,但随着ML算法的不断改进,在肝脏影像的应用逐步增多,如对慢性肝... 机器学习(ML)是指计算机通过大量数据训练及分析来模拟人类的学习行为从而获得新的知识和技能,是人工智能的核心。目前,ML在肝脏疾病方面的研究因影像分割困难而相对较少,但随着ML算法的不断改进,在肝脏影像的应用逐步增多,如对慢性肝病的筛查和病情严重程度评估;肝脏局灶性病变的鉴别和分类,辅助医生诊断;肝病图像分割算法的改进,图像质量的自动评估等。就ML的概念、发展、常见算法以及ML在肝脏疾病影像诊断中的研究进展进行系统回顾和介绍。 展开更多
关键词 机器学习 人工智能 肝脏成像 慢性肝病 肝癌
下载PDF
Impact of intra-operative cholangiography and parenchymal resection to donor liver function in living donor liver transplantation 被引量:1
8
作者 Feng Gao Xiao Xu +8 位作者 Yang-Bo Zhu Qiang Wei Bin Zhou Xiao-Yong Shen Qi Ling Hai-Yang Xie Jian Wu Wei-Lin Wang Shu-Sen Zheng 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2014年第3期259-263,共5页
BACKGROUND: Living donor liver transplantation(LDLT)has been widely accepted over the past decade, and hepatic dysfunction often occurs in the donor in the early stage after liver donation. The present study aimed to ... BACKGROUND: Living donor liver transplantation(LDLT)has been widely accepted over the past decade, and hepatic dysfunction often occurs in the donor in the early stage after liver donation. The present study aimed to evaluate the effect of intraoperative cholangiography(IOC) and parenchymal resection on liver function of donors in LDLT, and to assess the role of IOC in influencing the biliary complications and improving the overall outcome.METHODS: Data from 40 patients who had donated their right lobes for LDLT were analyzed. Total bilirubin(TB), alanine aminotransferase(ALT), aspartate aminotransferase(AST),alkaline phosphatase(ALP) and γ-glutamyl transpeptidase(GGT)at different time points were compared, and the follow-up data and the biliary complications were also analyzed.RESULTS: The ALT and AST values were significantly increased after IOC(P<0.001) and parenchymal resection(P<0.001).However, the median values of TB, ALP and GGT were not significantly influenced by IOC(P>0.05) or parenchymal resection(P>0.05). The biochemical changes caused by IOC or parenchymal resection were not correlated with the degree of post-operative liver injury or the recovery of liver function. The liver functions of the donors after operation were stable, and none of the donors suffered from biliary stenosis or leakage during the follow-up.CONCLUSIONS: IOC and parenchymal resection may induce a transient increase in liver enzymes of donors in LDLT, but do not affect the recovery of liver function after operation. Moreover,the routine IOC is helpful to clarify the division line of the hepatic duct, thus reducing the biliary complication rate. 展开更多
关键词 living donor liver transplantation INTRA-OPERATIVE liver imaging liver function HEPATECTOMY
下载PDF
对比剂碘浓度在双源双能量CT检查中对血管和肝脏强化的影响 被引量:5
9
作者 赵林伟 董国礼 +2 位作者 杨国庆 赵秀华 冯敏 《川北医学院学报》 CAS 2016年第4期447-451,共5页
目的:根据体表面积(body surface area,BSA)调整碘剂量(17.1 g I/m2BSA)、固定注射时间(25 s),比较双能量CT(dual energy CT,DECT)增强扫描中两种不同碘浓度对比剂之间血管和肝实质的强化。方法:300例患者被前瞻性随机分为4组,A组及C组... 目的:根据体表面积(body surface area,BSA)调整碘剂量(17.1 g I/m2BSA)、固定注射时间(25 s),比较双能量CT(dual energy CT,DECT)增强扫描中两种不同碘浓度对比剂之间血管和肝实质的强化。方法:300例患者被前瞻性随机分为4组,A组及C组注射300 mg/m L对比剂,B组及D组注射370 mg/m L对比剂,碘剂量根据BSA调整,对比剂注射时间固定为25 s。分别于肝动脉晚期(A、B组)或门静脉期(C、D组)采用双能量扫描,在80 k Vp、140 k Vp及彩色编码碘覆盖图中,比较高、低碘浓度对比剂间腹主动脉、门静脉及肝实质强化程度。组间强化程度差异采用Mann-Whitney U检验。结果:在80 k Vp、140 k Vp或彩色编码碘覆盖图中,注射高碘浓度对比剂时,动脉期主动脉平均强化程度较高,但两组差异没有统计学意义;两种碘浓度对比剂间门静脉期门静脉及各扫描期内肝实质强化程度差异没有统计学意义(P>0.05)。结论:在肝脏增强DECT成像中,根据BSA调整碘剂量,固定注射时间,注射300 mg I/m L或370 mg I/m L对比剂,可获得相等的血管及肝实质的强化。 展开更多
关键词 对比剂 对比强化 双能量CT 肝脏成像
下载PDF
Dynamic Contrast-Enhanced MRI of Mouse Liver: A Feasibility Study Using a Dual-Input Two-Compartment Tracer Kinetic Model
10
作者 Septian Hartono Choon Hua Thng +2 位作者 Kai Hsiang Chuang Huynh Hung Tong San Koh 《Journal of Biomedical Science and Engineering》 2015年第2期90-97,共8页
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has been widely applied to evaluate microcirculatory parameters in clinical settings. However, pre-clinical studies involving DCE-MRI of small animals rem... Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has been widely applied to evaluate microcirculatory parameters in clinical settings. However, pre-clinical studies involving DCE-MRI of small animals remain challenging with the requirement for high spatial and temporal resolution for quantitative tracer kinetic analysis. This study illustrates the feasibility of applying a high temporal resolution (2 s) protocol for liver imaging in mice by analyzing the DCE-MRI datasets of mice liver with a dual-input two-compartment tracer kinetic model. Phantom studies were performed to validate the T1 estimates derived by the proposed protocol before applying it in mice studies. The DCE-MRI datasets of mice liver were amendable to tracer kinetic analysis using a dual-input two-compartment model. Estimated micro-circulatory parameters were consistent with liver physiology, indicating viability of applying the technique for pre-clinical drug developments. 展开更多
关键词 DCE-MRI Mouse liver imaging PRECLINICAL imaging
下载PDF
桂附理中汤治疗非酒精性脂肪性肝病临床研究 被引量:1
11
作者 关红孝 李德珍 +1 位作者 路亚民 安德明 《中医临床研究》 2021年第36期88-90,共3页
目的:观察桂附理中汤治疗非酒精性脂肪性肝病(Non-alcoholic Fatty Liver Disease,NAFLD)的临床疗效。方法:将100例NAFLD患者随机分为观察组和对照组,每组50例。观察组服用桂附理中汤,对照组服用蒲参胶囊。3个月后对比两组临床症状、谷... 目的:观察桂附理中汤治疗非酒精性脂肪性肝病(Non-alcoholic Fatty Liver Disease,NAFLD)的临床疗效。方法:将100例NAFLD患者随机分为观察组和对照组,每组50例。观察组服用桂附理中汤,对照组服用蒲参胶囊。3个月后对比两组临床症状、谷丙转氨酶、谷草转氨酶、γ-氨酰转肽酶、血脂及肝脏影像学变化。结果:观察组证候积分、肝功能、血脂比较优于对照组(P<0.05)。结论:桂附理中汤可改善NAFLD的症状和体征、改善肝功能、降低血脂、部分恢复NAFLD的肝脏影像学改变,且无不良反应,具有临床应用价值。 展开更多
关键词 桂附理中汤 NAFLD 肝功能 血脂 肝脏影像学
下载PDF
FLAIR in Gd-EOB-DTPA Enhanced MRI: Does It Make a Difference?
12
作者 Makoto Hasegawa Miki Sugiyama +2 位作者 Nozomu Murata Masashi Nagamoto Tatsuya Gomi 《Open Journal of Radiology》 2017年第2期130-142,共13页
Background: Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA;gadoxetic acid disodium, Primovist, Bayer Healthcare, Berlin, Germany) is a gadolinium based contrast agent with hepatocyte specific... Background: Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA;gadoxetic acid disodium, Primovist, Bayer Healthcare, Berlin, Germany) is a gadolinium based contrast agent with hepatocyte specific properties. In patients scanned for hepatic metastasis using Gd-EOB-DTPA, it is important to differentiate hepatic metastasis with cysts and hemangiomas, which are the two most common benign lesions seen in the liver. Yet, in some cases it is difficult to differentiate these lesions. Purpose: The purpose of this study was to retrospectively investigate the usefulness of combining Fluid-attenuated inversion recovery (FLAIR) with Gd-EOB-DTPA enhanced MRI. Material and Methods: Gd-EOB-DTPA enhanced MRIs of 47 patients (19 male, 27 female) with a mean age of 68 years (range 32 - 85 years old) with a total of 121 lesions (68 cysts, 37 metastasis, 16 hemangiomas) were included in the study. T1WI, T2WI, heavy T2WI, dynamic contrast enhanced MRI, and FLAIR images of these lesions were evaluated. The patients were randomly divided into two groups (Groups A and B), and two independent radiologists were asked to give a diagnosis for each lesion. The radiologists were allowed to view FLAIR images for only Group B. Diagnostic performance regarding the differentiation of cysts, hemangiomas and metastases was assessed. MRI examinations were scanned using a 1.5 Tesla system (Echlon Vega, Hitachi,) with an 8 channel multiple array coil (RAPID body coil). Results: An statistically significant improvement (p < 0.05) of the specificity for cysts was seen from 71.9% (Group A) to 90.9% (Group B) for Reader 1, and 75.0% (Group A) to 93.3% (Group B) for Reader 2. No statistical differences were seen between the two groups for sensitivity and specificity of hemangiomas. Although no statistical difference was seen between the two groups, an improvement (77.8 in Group A to 97.2 in Group B for Reader 1, and 85.7 in Group A to 100 in Group B for Reader 2) was seen for the sensitivity of metastasis with the addition of FLAIR. Co 展开更多
关键词 MRI ABDOMEN liver imaging EOB FLAIR Heavy T2WI Metastasis HEMANGIOMA CYST
下载PDF
An Unusual Cause of Hepatic Portal Venous Gas
13
作者 Nizar Talaat Ritu Gupta 《Case Reports in Clinical Medicine》 2014年第5期267-271,共5页
A 27-years-old female with history of venous thromboembolism secondary to Lupus anticoagulant presented with sudden onset of chest pain and dyspnea. A CT angiogram of the chest showed superior vena caval (SVC) obstruc... A 27-years-old female with history of venous thromboembolism secondary to Lupus anticoagulant presented with sudden onset of chest pain and dyspnea. A CT angiogram of the chest showed superior vena caval (SVC) obstruction with anterior chest wall venous collaterals and hepatic portal vein gas (HPVG), which resolved without intervention on a repeated CT-scan of the abdomen. Previously, HPVG was considered to be a dangerous radiologic sign, however with the advancement in imaging technology more benign causes are being identified. This case highlights that this finding alone, if found, does not indicate aggressive management and that clinical correlation should be considered if found. 展开更多
关键词 HEPATIC PORTAL VENOUS Gas SUPERIOR Vena Cava SYNDROME liver imaging
下载PDF
Chilaiditi Syndrome
14
作者 Jean Marie Ovungu Pierlesky Elion Ossibi +7 位作者 Franck Mvumbi Ismael Dandakoye Soumana Badre Alami Meryem Boubbou Mustapha Maaroufi Khalid Mazaz Khalid Ait Taleb Youssef Lamrani 《Open Journal of Radiology》 2017年第3期164-169,共6页
The interposition of the colon or the small intestine between the liver and the diaphragm otherwise called Chilaiditi syndrome remains a rare condition. Its incidence varies between 0.025% and 0.28% according to recen... The interposition of the colon or the small intestine between the liver and the diaphragm otherwise called Chilaiditi syndrome remains a rare condition. Its incidence varies between 0.025% and 0.28% according to recent literature and is only found incidentally on diagnostic imaging. Hence, it constitutes a classic pitfall in the diagnosis of false right pneumoperitoneum. We deem interesting to report a case of Chilaiditi syndrome in a 44-year-old patient with no significant history who was admitted at emergency department for abdominal trauma following a road accident. 展开更多
关键词 Chilaiditi INTERPOSITION COLON Small INTESTINE DIAPHRAGM liver imaging
下载PDF
^(18)F-FDG异常肝脏显像药物质谱测定及失控原因分析 被引量:1
15
作者 梁万胜 张志琪 +3 位作者 朱虹 岳宣峰 卢樱 薛杨波 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第6期700-703,共4页
目的探讨2-氟18-β-D-脱氧葡萄糖(18F-FDG)异常肝脏显像的原因及质量控制中的隐藏问题。方法应用GC/MS和MS/MS质谱分析并根据分析结果制备模拟样品;用TLC、HPLC进行质量控制;使用C18和Amino色谱柱并改变放射性探测器样品池体积分析模拟... 目的探讨2-氟18-β-D-脱氧葡萄糖(18F-FDG)异常肝脏显像的原因及质量控制中的隐藏问题。方法应用GC/MS和MS/MS质谱分析并根据分析结果制备模拟样品;用TLC、HPLC进行质量控制;使用C18和Amino色谱柱并改变放射性探测器样品池体积分析模拟样品的放射化学纯度。隔日复查异常肝脏显像情况。结果GC/MS分析,结合NIST谱库检索,鉴定出药物中含有相对分子质量为376的化合物,名称为氨基聚醚K2.2.2(AminopolyetherK2.2.2);MS/MS分析,基峰为415.1,其次为377.2;模拟样品TLC分析见两个放射性峰,点样板碘显色可见接近原点处出现棕色斑点;HPLC分析模拟样品,因色谱柱和放射性探测器样品池体积的不同而结果不同;隔日PET/CT复查患者异常肝脏显像,肝脏高代谢消失。结论异常肝脏显像药物经质谱测定发现含有过量的K2.2.2,建议在药物放行前常规检测K2.2.2含量。 展开更多
关键词 2-氟18-β—D-脱氧葡萄糖 质谱 质量控制 氨基聚醚K2.2.2 肝显像
下载PDF
CT和MRI对乙肝肝硬化背景下肝细胞癌诊断评分的一致性:基于LI-RADS的多中心、个体内对照研究 被引量:30
16
作者 王可 郭小超 +6 位作者 王鹤 陆健 刘爱连 缪小芬 汪禾青 杨学东 王霄英 《放射学实践》 北大核心 2016年第4期291-295,共5页
目的:基于肝脏影像报告和数据系统(LI-RADS)2014版评分系统,探讨CT和MRI对乙肝肝硬化基础上的肝细胞肝癌(HCC)的诊断价值。方法:本研究为多中心、个体内对照研究,搜集51例(54个HCC病灶)经病理证实的慢性乙型肝炎肝硬化合并HCC患者的病... 目的:基于肝脏影像报告和数据系统(LI-RADS)2014版评分系统,探讨CT和MRI对乙肝肝硬化基础上的肝细胞肝癌(HCC)的诊断价值。方法:本研究为多中心、个体内对照研究,搜集51例(54个HCC病灶)经病理证实的慢性乙型肝炎肝硬化合并HCC患者的病例资料,所有患者均行CT和MRI平扫及动态增强扫描(两项检查间隔时间不超过1个月)。由2位不同年资的放射科医师根据LI-RADS标准分别对所有入组病例的动态增强CT、平扫联合动态增强MRI两个阅片单元进行独立盲法读片,每位阅片者每个单元读片结束后需等待至少一个月方能进入下个读片单元。通过Kappa检验对两位阅片者间的评分一致性进行分析。结果:两位阅片者对51例HCC患者CT图像进行评价,LI-RADS评分分别为4.13±1.10和4.07±1.13,一致性中等(Kappa=0.550);而基于平扫联合动态增强MRI,两位阅片者的LIRADS评分分别为4.61±0.65和4.31±0.91,一致性一般(Kappa=0.398)。结论:针对HCC病灶,使用LI-RADS进行诊断评分时,动态增强CT的阅片者间一致性较好,优于平扫联合动态增强MRI。 展开更多
关键词 肝细胞肝癌 肝脏影像报告及数据系统 体层摄影术 X线计算机 磁共振成像
下载PDF
超声造影LI—RADS分类在肝细胞癌诊断中的应用价值 被引量:26
17
作者 吴晓贝 罗鸿昌 +2 位作者 李开艳 李姗姗 黄哲 《中华超声影像学杂志》 CSCD 北大核心 2018年第11期936-941,共6页
目的探讨超声造影肝脏影像报告与数据系统(LI-RADS)在肝细胞癌(HCC)诊断中的应用价值。方法回顾性分析2012年10月至2018年7月于华中科技大学附属同济医院就诊的具有HCC高危风险的肝脏局灶性病变患者的超声造影资料,参照2017版超声造影LI... 目的探讨超声造影肝脏影像报告与数据系统(LI-RADS)在肝细胞癌(HCC)诊断中的应用价值。方法回顾性分析2012年10月至2018年7月于华中科技大学附属同济医院就诊的具有HCC高危风险的肝脏局灶性病变患者的超声造影资料,参照2017版超声造影LI-RADS分类标准对178例患者的197个病灶进行分级。以手术病理作为最终诊断,评价超声造影LI-RADS分类与病理诊断之间的关系。结果197个病灶的最大径平均为(2.9±1.6)cm,经病理证实HCC170个(86.3%),非HCC恶性病变17个(8.6%),肝脏良性病变10个(5。1%)。超声造影LI-RADS分类LR-3、LR-4、LR-5、LR-M类分别有6个(3.0%)、37个(18.8%)、134个(68.0%)、20个(10.2%)。LR-3、LR-4、LR-5类病灶诊断HCC的阳性预测值分别为16.7%(1/6)、89.2%(33/37)、97.0%(130/134),LR-5类诊断HCC的阳性预测值最高,但敏感性偏低(76.5%),若将LR-4+LR-5类诊断为HCC,其诊断准确度明显优于LR-5类(92.4%对77.7%),差异有统计学意义(P<0.05)。LR-M中95.0%(19/20)的病灶为恶性病变,其中HCC6个。76.9%(10/13)的胆内胆管细胞癌超声造影表现为LR-M类。结论超声造影LI-RADS分类标准对HCC的诊断及鉴别诊断具有较高的应用价值。 展开更多
关键词 超声造影 肝细胞癌 肝脏影像学报告与数据系统(LI-RADS)
原文传递
2018版MRI肝脏影像报告和数据系统对≤3 cm肝细胞癌与其他肝脏原发恶性肿瘤的鉴别诊断价值 被引量:24
18
作者 李炳荣 张坤 +5 位作者 严小斌 雷丽燕 赵雪妙 王祖飞 吕桂坚 纪建松 《中华放射学杂志》 CAS CSCD 北大核心 2021年第2期166-172,共7页
目的:探讨2018版MRI肝脏影像报告和数据系统(LI-RADS v2018)对≤3 cm肝细胞癌(HCC)与其他肝脏原发恶性肿瘤(OM)的鉴别诊断价值。方法:回顾性分析2014年9月至2019年9月间浙江省丽水市中心医院、丽水市遂昌人民医院经手术病理证实且病灶... 目的:探讨2018版MRI肝脏影像报告和数据系统(LI-RADS v2018)对≤3 cm肝细胞癌(HCC)与其他肝脏原发恶性肿瘤(OM)的鉴别诊断价值。方法:回顾性分析2014年9月至2019年9月间浙江省丽水市中心医院、丽水市遂昌人民医院经手术病理证实且病灶长径≤3 cm的95例原发肝癌患者资料,根据病理结果分别归入HCC组(53例)和OM组(42例,其中肿块型肝内胆管细胞癌31例、混合型肝癌11例)。分析病灶的MRI征象,并依据LI-RADS v2018标准对病灶进行分类。两组间MRI征象比较采用χ^2检验。以病理结果为金标准,计算LI-RADS v2018分类标准诊断HCC或OM的灵敏度和特异度。结果:HCC组和OM组间动脉期强化表现、廓清表现、假包膜征、脂肪变性、出血、填充强化的差异有统计学意义(P<0.05)。HCC组LI-RADS v2018分类结果归类为LR-M、LR-3、LR-4、LR-5的例数分别为7、1、11、34例,OM组分别为15、1、15、11例。以LR-5标准诊断HCC的灵敏度为64.2%(34/53)、特异度为73.8%(31/42);以LR-4联合LR-5标准诊断HCC的灵敏度为84.9%(45/53)、特异度为38.1%(16/42);以LR-M标准诊断OM的灵敏度为35.7%(15/42)、特异度为86.8%(46/53)。结论:当肝内病灶长径≤3 cm时,以LR-4联合LR-5、LR-5为标准诊断HCC的特异度较低,以LR-M为标准诊断OM有较高的特异度。 展开更多
关键词 肝肿瘤 磁共振成像 肝脏影像报告和数据系统
原文传递
超声造影肝影像报告和数据系统与磁共振肝影像报告和数据系统对肝细胞癌高危患者肝占位性病变的一致性评价研究 被引量:24
19
作者 李小娟 黄品同 +3 位作者 徐永远 李世岩 陈军法 尹鹏涛 《中华超声影像学杂志》 CSCD 北大核心 2020年第6期522-528,共7页
目的探讨肝细胞肝癌高危患者肝脏占位性病变的超声造影肝脏影像报告和数据系统(contrast-enhanced ultrasound liver imaging reporting and data system,CEUS LI-RADS)与磁共振肝脏影像报告和数据系统(magnetic resonance imaging live... 目的探讨肝细胞肝癌高危患者肝脏占位性病变的超声造影肝脏影像报告和数据系统(contrast-enhanced ultrasound liver imaging reporting and data system,CEUS LI-RADS)与磁共振肝脏影像报告和数据系统(magnetic resonance imaging liver imaging reporting and data system,MRI LI-RADS)分类的一致性。方法回顾性分析2017年8月至2019年8月在浙江大学医学院附属第二医院就诊的173例肝细胞肝癌高危患者肝脏占位性病变(217个病灶)的影像学资料,分别由2名超声造影(CEUS)与磁共振成像(MRI)诊断医师按照CEUS LI-RADS 2017版和MRI LI-RADS 2018版分类标准对病灶进行判读,通过Kappa检验评估观察者间及两种影像学LI-RADS分类的一致性。结果CEUS LI-RADS观察者间一致性与MRI相当(Kappa=0.606、0.603);CEUS LI-RADS与MRI LI-RADS两种影像学总的一致性中等(Kappa=0.564),其中两种影像学对LI-RADS-3、M、4和5类的一致性分析,其Kappa值分别为0.739、0.551、0.734、0.592。结论CEUS LI-RADS与MRI LI-RADS分类总的一致性中等,其中LI-RADS-3、4类一致性较强,LI-RADS-M、5类一致性中等。 展开更多
关键词 超声造影 肝细胞癌 肝脏影像报告和数据系统 肝硬化 磁共振成像
原文传递
基于钆塞酸二钠增强MRI采用2018版LI-RADS诊断肝细胞癌的效能 被引量:21
20
作者 杨采薇 蒋涵羽 +1 位作者 宋彬 陈婕 《中华放射学杂志》 CAS CSCD 北大核心 2019年第12期1060-1064,共5页
目的探讨基于钆塞酸二钠(Gd-EOB-DTPA)增强MRI采用2018版肝脏报告及影像数据系统(LI-RADS)在高危人群中诊断肝细胞癌(HCC)的效能.方法回顾性分析四川大学华西医院2015年7月至2018年9月,行Gd-EOB-DTPA增强MRI并于1个月内进行肝切除术的13... 目的探讨基于钆塞酸二钠(Gd-EOB-DTPA)增强MRI采用2018版肝脏报告及影像数据系统(LI-RADS)在高危人群中诊断肝细胞癌(HCC)的效能.方法回顾性分析四川大学华西医院2015年7月至2018年9月,行Gd-EOB-DTPA增强MRI并于1个月内进行肝切除术的130例肝硬化高危结节患者(134个局灶性肝脏病灶).由2名放射科医师进行独立盲法阅片,根据2018版LI-RADS评估每个病灶的主要征象、辅助征象及LI-RADS分级,以术后病理结果为金标准评估2名医师诊断的一致性(Kappa检验)及效能.结果2名医师间LI-RADS分类的Kappa值为0.628(95%可信区间0.565~0.691),一致性良好.LR-5作为诊断标准,医师1根据2018版LI-RADS诊断HCC的灵敏度、特异度、约登指数和准确率分别为80.4%(78/97)、75.7%(28/37)、0.5608和79.1%(106/134),医师2分别为87.6%(85/97)、73.0%(27/37)、0.6059和83.6%(112/136).LR-4+LR-5作为诊断标准,医师1根据2018版LI-RADS诊断HCC的灵敏度、特异度、约登指数和准确率分别为91.8%(85/97)、67.6%(25/37)、0.5931和82.1%(110/134),医师2分别为96.9%(94/97)、67.6%(25/37)、0.6446和88.8%(119/134).结论基于Gd-EOB-DTPA增强MRI,2018版LI-RADS在高危人群中诊断HCC具有较高的灵敏度及准确率. 展开更多
关键词 肝肿瘤 磁共振成像 造影剂 肝脏影像报告及数据系统
原文传递
上一页 1 2 10 下一页 到第
使用帮助 返回顶部